Related Experiment Video
Updated: Jul 27, 2026
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Lipid nanoparticles-loaded with toxin mRNA represents a new strategy for the treatment of solid tumors
Yasmin Granot-Matok1,2,3,4, Assaf Ezra1,2,3,4, Srinivas Ramishetti1,2,3,4
1Laboratory of Precision NanoMedicine, Shmunis School for Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel.
Abstract:
Background and rationale: Cancer therapy have evolved remarkably over the past decade, providing new strategies to inhibit cancer cell growth using immune modulation, with or without gene therapy. Specifically, suicide gene therapies and immunotoxins have been investigated for the treatment of tumors by direct cancer cell cytotoxicity. Recent advances in mRNA delivery also demonstrated the potential of mRNA-based vaccines and immune-modulators for cancer therapeutics by utilizing nanocarriers for mRNA delivery. Methods: We designed a bacterial toxin-encoding modified mRNA, delivered by lipid nanoparticles into a B16-melanoma mouse model. Results: We showed that local administration of LNPs entrapping a modified mRNA that encodes for a bacterial toxin, induced significant anti-tumor effects and improved overall survival of treated mice. Conclusions: We propose mmRNA-loaded LNPs as a new class of anti-tumoral, toxin-based therapy.
Insights
Modified mRNA encoding a bacterial toxin, delivered via lipid nanoparticles, demonstrated significant anti-tumor effects in a mouse model. This novel approach offers a promising new avenue for cancer therapy.
Area of Science:
- Oncology
- Immunotherapy
- Gene Therapy
Background:
- Cancer therapy has advanced with immune modulation and gene therapy strategies.
- Suicide gene therapies and immunotoxins target cancer cells directly.
- Messenger RNA (mRNA) delivery systems show promise for cancer vaccines and immune modulators.
Purpose of the Study:
- To investigate the efficacy of bacterial toxin-encoding modified mRNA delivered by lipid nanoparticles for cancer treatment.
Main Methods:
- Developed modified mRNA encoding a bacterial toxin.
- Utilized lipid nanoparticles (LNPs) for mRNA delivery.
- Administered LNPs intratumorally in a B16-melanoma mouse model.
Main Results:
- Local administration of mRNA-loaded LNPs induced significant anti-tumor effects.
- Treated mice showed improved overall survival compared to controls.
Conclusions:
- Modified mRNA-loaded lipid nanoparticles represent a novel class of toxin-based anti-cancer therapy.
- This approach warrants further investigation for clinical translation.
